WO2001000187A3 - Pharmaceutical composition containing sibutramine and a lipase inhibitor - Google Patents
Pharmaceutical composition containing sibutramine and a lipase inhibitor Download PDFInfo
- Publication number
- WO2001000187A3 WO2001000187A3 PCT/EP2000/005544 EP0005544W WO0100187A3 WO 2001000187 A3 WO2001000187 A3 WO 2001000187A3 EP 0005544 W EP0005544 W EP 0005544W WO 0100187 A3 WO0100187 A3 WO 0100187A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lipase inhibitor
- pharmaceutical composition
- composition containing
- containing sibutramine
- human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Abstract
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001505897A JP2003503344A (en) | 1999-06-24 | 2000-06-16 | Remedies |
IL14707800A IL147078A0 (en) | 1999-06-24 | 2000-06-16 | Therapeutic agents |
BR0011884-2A BR0011884A (en) | 1999-06-24 | 2000-06-16 | Method of treating obesity and comorbid conditions in a human in need of such treatment, compound of formula i, product containing compound of formula i, use of compound of formula i, and pharmaceutical composition |
KR1020017016577A KR20020012293A (en) | 1999-06-24 | 2000-06-16 | Therapeutic Agents |
EP00943819A EP1189638A2 (en) | 1999-06-24 | 2000-06-16 | Pharmaceutical composition containing sibutramine and a lipase inhibitor |
AU58151/00A AU5815100A (en) | 1999-06-24 | 2000-06-16 | Therapeutic agents |
MXPA01013023A MXPA01013023A (en) | 1999-06-24 | 2000-06-16 | Therapeutic agents. |
CA002376213A CA2376213A1 (en) | 1999-06-24 | 2000-06-16 | Therapeutic agents |
HU0201880A HUP0201880A3 (en) | 1999-06-24 | 2000-06-16 | Pharmaceutical composition containing sibutramine and a lipase inhibitor |
SK1882-2001A SK18822001A3 (en) | 1999-06-24 | 2000-06-16 | Therapeutic agents |
BG06209A BG106209A (en) | 1999-06-24 | 2001-12-11 | Therapeutic agents |
NO20016301A NO20016301L (en) | 1999-06-24 | 2001-12-21 | Therapeutic agents |
HK03101311.7A HK1050476A1 (en) | 1999-06-24 | 2003-02-20 | Pharmaceutical composition containing sibutramine and a lipase inhibitor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9914742.3 | 1999-06-24 | ||
GBGB9914742.3A GB9914742D0 (en) | 1999-06-24 | 1999-06-24 | Therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001000187A2 WO2001000187A2 (en) | 2001-01-04 |
WO2001000187A3 true WO2001000187A3 (en) | 2001-11-15 |
Family
ID=10855953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/005544 WO2001000187A2 (en) | 1999-06-24 | 2000-06-16 | Pharmaceutical composition containing sibutramine and a lipase inhibitor |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1189638A2 (en) |
JP (1) | JP2003503344A (en) |
KR (1) | KR20020012293A (en) |
CN (1) | CN1365287A (en) |
AU (1) | AU5815100A (en) |
BG (1) | BG106209A (en) |
BR (1) | BR0011884A (en) |
CA (1) | CA2376213A1 (en) |
CZ (1) | CZ20014614A3 (en) |
GB (1) | GB9914742D0 (en) |
HK (1) | HK1050476A1 (en) |
HU (1) | HUP0201880A3 (en) |
IL (1) | IL147078A0 (en) |
MX (1) | MXPA01013023A (en) |
NO (1) | NO20016301L (en) |
PL (1) | PL352387A1 (en) |
SK (1) | SK18822001A3 (en) |
TR (1) | TR200103704T2 (en) |
WO (1) | WO2001000187A2 (en) |
ZA (1) | ZA200110046B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399826B1 (en) * | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
US7089666B2 (en) * | 2003-06-06 | 2006-08-15 | The Regents Of The University Of California | Microfabricated vertical comb actuator using plastic deformation |
US8604244B2 (en) | 2010-07-02 | 2013-12-10 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives |
EP2066329B1 (en) | 2006-09-15 | 2017-09-06 | Reviva Pharmaceuticals, Inc. | Synthesis, methods of using, and compositions of cyclobutylmethylamines |
CN101890017A (en) * | 2009-05-22 | 2010-11-24 | 北京奥萨医药研究中心有限公司 | Medicament composition containing sibutramine and stanin fat-reducing medicament and application thereof |
US9238625B2 (en) | 2011-12-30 | 2016-01-19 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives |
-
1999
- 1999-06-24 GB GBGB9914742.3A patent/GB9914742D0/en not_active Ceased
-
2000
- 2000-06-16 IL IL14707800A patent/IL147078A0/en unknown
- 2000-06-16 CZ CZ20014614A patent/CZ20014614A3/en unknown
- 2000-06-16 SK SK1882-2001A patent/SK18822001A3/en unknown
- 2000-06-16 HU HU0201880A patent/HUP0201880A3/en unknown
- 2000-06-16 WO PCT/EP2000/005544 patent/WO2001000187A2/en not_active Application Discontinuation
- 2000-06-16 KR KR1020017016577A patent/KR20020012293A/en not_active Application Discontinuation
- 2000-06-16 TR TR2001/03704T patent/TR200103704T2/en unknown
- 2000-06-16 BR BR0011884-2A patent/BR0011884A/en not_active IP Right Cessation
- 2000-06-16 AU AU58151/00A patent/AU5815100A/en not_active Abandoned
- 2000-06-16 MX MXPA01013023A patent/MXPA01013023A/en unknown
- 2000-06-16 CA CA002376213A patent/CA2376213A1/en not_active Abandoned
- 2000-06-16 CN CN00810544A patent/CN1365287A/en active Pending
- 2000-06-16 PL PL00352387A patent/PL352387A1/en unknown
- 2000-06-16 EP EP00943819A patent/EP1189638A2/en not_active Withdrawn
- 2000-06-16 JP JP2001505897A patent/JP2003503344A/en active Pending
-
2001
- 2001-12-06 ZA ZA200110046A patent/ZA200110046B/en unknown
- 2001-12-11 BG BG06209A patent/BG106209A/en unknown
- 2001-12-21 NO NO20016301A patent/NO20016301L/en not_active Application Discontinuation
-
2003
- 2003-02-20 HK HK03101311.7A patent/HK1050476A1/en unknown
Non-Patent Citations (1)
Title |
---|
BUTTLE L.A.: "Anti-obesity drugs: On target for huge market sales", EXPERT OPINION ON INVESTIGATIONAL DRUGS(EXPERT OPIN. INVEST. DRUGS), 5/12 (1583-1587), United Kingdom, XP002105328 * |
Also Published As
Publication number | Publication date |
---|---|
MXPA01013023A (en) | 2003-08-01 |
CZ20014614A3 (en) | 2004-02-18 |
BR0011884A (en) | 2003-08-12 |
ZA200110046B (en) | 2003-03-06 |
CA2376213A1 (en) | 2001-01-04 |
TR200103704T2 (en) | 2002-05-21 |
HUP0201880A3 (en) | 2003-03-28 |
BG106209A (en) | 2002-09-30 |
SK18822001A3 (en) | 2003-04-01 |
PL352387A1 (en) | 2003-08-25 |
AU5815100A (en) | 2001-01-31 |
WO2001000187A2 (en) | 2001-01-04 |
EP1189638A2 (en) | 2002-03-27 |
NO20016301D0 (en) | 2001-12-21 |
KR20020012293A (en) | 2002-02-15 |
GB9914742D0 (en) | 1999-08-25 |
IL147078A0 (en) | 2002-08-14 |
JP2003503344A (en) | 2003-01-28 |
CN1365287A (en) | 2002-08-21 |
HK1050476A1 (en) | 2003-06-27 |
NO20016301L (en) | 2001-12-21 |
HUP0201880A2 (en) | 2002-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003000343A3 (en) | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation | |
AU2003225617A1 (en) | Thiadiazolylpiperazine derivatives useful for treating or preventing pain | |
AU7031500A (en) | Therapeutic quinazoline compounds | |
NZ514574A (en) | Novel method of treatment | |
GB2254784B (en) | Film-coated solid dosage form of anti-migraine drug | |
GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
GEP20043324B (en) | Purine Derivatives | |
FI973163A (en) | Treatment of incontinence using (S) -oxybutynin and (S) -desethyloxybutynin | |
WO1999033450A3 (en) | Pharmaceutical composition containing sibutramine and orlistat | |
AU3850600A (en) | Dalda analogs and their use | |
WO2000071108A3 (en) | Methods for treatment of asthma using s-oxybutynin | |
MXPA01012936A (en) | Pharmaceutical composition containing sibutramine and orlistat. | |
WO2001000187A3 (en) | Pharmaceutical composition containing sibutramine and a lipase inhibitor | |
AU2420001A (en) | Methods and compositions for the treatment of pain | |
WO2005055933A3 (en) | Treatment of psoriasis with rosiglitazone | |
MY133438A (en) | Morpholinobenzamide salts | |
AP9801235A0 (en) | Erythromycin derivatives. | |
SE9800905D0 (en) | New therapy in glomerulonephritis | |
WO2002041841A3 (en) | Compositions for adhesion prevention | |
WO2004073627A3 (en) | Novel therapeutic method and compositions for topical administration | |
WO2005035500A3 (en) | Therapeutic agents useful for treating pain | |
WO1999033454A3 (en) | S-procyclidine for treating urinary incontinence | |
WO2004050019A9 (en) | Method and compositions for treating anxiety | |
WO2003004019A8 (en) | Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia | |
WO1999033453A3 (en) | R-procyclidine for treating urinary incontinence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200110046 Country of ref document: ZA |
|
ENP | Entry into the national phase |
Ref document number: 2000 106209 Country of ref document: BG Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2376213 Country of ref document: CA Ref document number: 2376213 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 516141 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/013023 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-4614 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 58151/00 Country of ref document: AU Ref document number: 18822001 Country of ref document: SK |
|
ENP | Entry into the national phase |
Ref document number: 2001 505897 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: IN/PCT/2001/1796/CHE Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017016577 Country of ref document: KR Ref document number: 2001/03704 Country of ref document: TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000943819 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 008105448 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 2002 2002102075 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20020067A Country of ref document: HR |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017016577 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2000943819 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10009843 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000943819 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV2001-4614 Country of ref document: CZ |
|
WWR | Wipo information: refused in national office |
Ref document number: 1020017016577 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2001-4614 Country of ref document: CZ |